Cardiovascular risks associated with dipeptidyl peptidase‐4 inhibitors monotherapy compared with other antidiabetes drugs in the Japanese population: A nationwide cohort study-Reference-Cited by-同舟云学术

Cardiovascular risks associated with dipeptidyl peptidase‐4 inhibitors monotherapy compared with other antidiabetes drugs in the Japanese population: A nationwide cohort study

Published:2019-07-23 Issue:9 Volume:28 Page:1166-1174
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Komamine Maki¹^ORCID,Kajiyama Kazuhiro¹^ORCID,Ishiguro Chieko¹^ORCID,Uyama Yoshiaki¹^ORCID

Affiliation:

1. Office of Medical Informatics and EpidemiologyPharmaceuticals and Medical Devices Agency Tokyo Japan

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pds.4847

Reference32 articles.

1. Dipeptidyl peptidase-4 inhibitors in the treatment of type 2 diabetes: a comparative review

2. The Glucose-lowering Efficacy of Sitagliptin in Obese Japanese Patients with Type 2 Diabetes

3. Evidence‐based Practice Guideline for the Treatment of Diabetes in Japan 2013. Nankodo Co Ltd2013.

4. Diabetes and Atherosclerosis

5. Cardiovascular safety profile of currently available diabetic drugs;Azimova K;Ochsner J,2014

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of cancer risk associated with 7‐nitroso‐3‐(trifluoromethyl)‐5,6,7,8‐tetrahydro[1,2,4] triazolo‐[4,3‐a]pyrazine‐contaminated sitagliptin use: A retrospective cohort study;Journal of Diabetes Investigation;2024-08-12

2. Literature Review of Studies Using the National Database of the Health Insurance Claims of Japan (NDB): Limitations and Strategies in Using the NDB for Research;JMA Journal;2024

3. Prescription patterns and therapeutic effects of second-line drugs in Japanese patients with type 2 diabetes mellitus: Analysis of claims data for metformin and dipeptidyl peptidase-4 inhibitors as the first-line hypoglycemic agents;Expert Opinion on Pharmacotherapy;2023-04-26

4. Statin persistence and adherence among older initiators: A nationwide cohort study using the national health insurance claims database in Japan;Pharmacoepidemiology and Drug Safety;2023-04

5. Use of National Database of Health Insurance Claims and Specific Health Checkups for examining practical utilization and safety signal of a drug to support regulatory assessment on postmarketing drug safety in Japan;Frontiers in Medicine;2023-02-23